Metraipolis › archive › dc_af76ce998c98

Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical… — Europe PMC PMID:41096574

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41096574
DOI
10.3390/ijms26199305
License (as archived)
solo-consultazione
Archived
2026-11-09T19:23:43.699Z
SHA-256 of the archived text
970abc268b37801a018a6f5acea2511c280f5c2f18812b6668c56dbd2a0ed865
Stable URL of this page
https://metraipolis.com/documento/dc_af76ce998c98

How to cite

Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical… — Europe PMC PMID:41096574 — Europe PMC (en), https://europepmc.org/article/MED/41096574 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af76ce998c98 (Metraipolis archive dc_af76ce998c98, sha256 970abc268b37801a018a6f5acea2511c280f5c2f18812b6668c56dbd2a0ed865)
BibTeX
@misc{dcaf76ce998c98,
  title = {Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical… — Europe PMC PMID:41096574},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41096574},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af76ce998c98; sha256 970abc268b37801a018a6f5acea2511c280f5c2f18812b6668c56dbd2a0ed865},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41096574. Agents can read the archived copy with the MCP tool read_document.